To treat or not to treat?: The judicious use of interferon-α-2a for the treatment of chronic hepatitis B
- 31 December 1993
- journal article
- research article
- Published by Elsevier in Journal of Hepatology
- Vol. 17, S42-S46
- https://doi.org/10.1016/s0168-8278(05)80422-2
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Randomised controlled trial of lymphoblastoid interferon alfa in Europid men with chronic hepatitis B virus infection.BMJ, 1989
- Changes of hepatitis B virus (HBV) markers during prolonged recombinant interferon alpha-2A treatment of chronic HBV infectionJournal of Hepatology, 1987
- A randomised controlled trial with human lymphoblastoid interferon vs no treatment in chronic hepatitis B virus infection: Preliminary resultsJournal of Hepatology, 1986
- Randomised controlled trial of lymphoblastoid interferon for chronic active hepatitis BJournal of Hepatology, 1986
- Lymphoblastoid and recombinant α-A Interferon therapy of chronic hepatitis B virus infection: The royal free hospital experienceJournal of Hepatology, 1986
- Modification of Hepatitis B Virus Infection by Recombinant Leukocyte Alpha A InterferonImmunobiology, 1986
- Pilot study of recombinant human α-interferon for chronic type B hepatitisGastroenterology, 1986
- Recombinant Leukocyte Interferon Treatment of Chronic Hepatitis BHepatology, 1985
- Recombinant Leukocyte A Interferon Treatment in Patients With Chronic Hepatitis B Virus InfectionGastroenterology, 1985
- Acute Dane Particle Suppression with Recombinant Leukocyte A Interferon in Chronic Hepatitis B Virus InfectionThe Journal of Infectious Diseases, 1983